Early research (Phase 1)Study completedNCT00730613
What this trial is testing
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Who this might be right for
Brain and Central Nervous System Tumors
City of Hope Medical Center 3